Robyn Meurant

Lead Diagnostics Development


Novateur Advisor Since



IVD Regulatory Assessment, Technical Documentation Assessment, Guidance Development Assessment, Regulatory Capacity Building



"If the COVID-19 pandemic has taught the world anything, it is the importance of good quality IVDs. At Novateur, that is our goal - that the IVDs we work with will be of good quality and will have a positive impact on patient care."

Robyn Meurant
Lead Diagnostics Development

Ms Meurant was the regulator of IVDs for the Australian Therapeutic Goods Administration, led technical documentation assessment and guidance development for WHO PQ, was the global lead for IVDs at NSF Health Sciences, and has been advising governments and NGOs during the COVID-19 pandemic. She has also extensive experience in regulatory capacity building. She commenced her career as a diagnostic scientist, heading the serology laboratories of several of the largest pathology providers in Australia.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!